Suchergebnisse - (Person:"Gökmen-Polar, Yesim")

PubPharm (78)

71

Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer

enthalten in: Breast cancer research and treatment | 2010

von Gökmen-Polar, Y. | Toroni, R. | Hocevar, B. | +6

72

Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer

enthalten in: Breast cancer research and treatment | 2010

von Gökmen-Polar, Y. | Toroni, R. | Hocevar, B. | +6

73

Promise of computational systems biology for cancer clinical trials : the voyage to be realized?

enthalten in: Personalized medicine | 2010

von Gökmen-Polar, Y. | Badve, S.

74

Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes

enthalten in: Breast cancer research and treatment | 2010

von Gökmen-Polar, Y. | Mehta, R. | Tuzmen, S. | +8

75

Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes

enthalten in: Breast cancer research and treatment | 2010

von Gökmen-Polar, Y. | Mehta, R. | Tuzmen, S. | +8

76

Redefining the target again : chemotherapeutics as vascular disrupting agents?

enthalten in: Cancer cell | 2008

von Gokmen-Polar, Y. | Miller, K.

CommentOn: Cancer Cell. 2008 Sep 9;14(3):263-73. - PMID 18772115

77

A comparative proteomic study to characterize the vinblastine resistance in human ovarian cancer cells

enthalten in: Proteomics. Clinical applications | 2007

von Brown, D. | Gökmen-Polar, Y. | Jiang, L. | +7

78

Protein Kinase Cι Is Required for Ras Transformation and Colon Carcinogenesis in vivo

Erschienen: 2004

von Murray, N. | Jamieson, L. | Yu, W. | +7

[1]
« Vorheriger
1
2
3
4
5
6
7
8